AzTrials
AzTrials

Lumbar RadiculopathyNCT03185442

Cerebral Effects of Pulsed Radiofrequency on the Lumbar Dorsal Root Ganglion With Functional Magnetic Resonance Imaging.

A study testing Pulsed Radiofrequency in people with Lumbar Radiculopathy and Chronic Disease, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation of central (cerebral) effects of Pulsed RadioFrequency (PRF) on the lumbar DRG (Dorsal Root Ganglion), using fMRI (functional Magnetic Resonance Imaging ). Feasibility study (after which an interim analysis is done): 5 subjects in order to detect measurable central effects inducted by PRF on DRG, follow up… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Lumbar Radiculopathy, Chronic Disease
What is being tested?
Pulsed Radiofrequency
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteBelgium
Study dates
2 Jul 2018to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-75 y
  • Radicular pain in lumbar region more than 6 weeks, neuropathic

Who cannot join

  • Coagulopathy
  • Implanted PM or SCS device
  • Pregnancy
  • Unwilling to undergo MRI
  • Psychiatric disorders

Trial locations and contacts

1 site in 1 country.

Veerle Van Mossevelde, Data Nurse contact

+3224763134

veerle.vanmossevelde@uzbrussel.be

Dirk De Clippeleir, Data Nurse contact

+324763580

dirk.declippeleir@uzbrussel.be

Belgium1 site, 1 recruiting
  • Pain Clinic Universitair Ziekenhuis Brussel

    Jette, Vlaams Brabant, 1090

    Veerle Van Mossevelde, Study Nurse, +3224763134, veerle.vanmossevelde@uzbrussel.be

    Dirk De Clippeleir, Study Nurse, +3224763580, dirk.declippeleir@uzbrussel.be

    Recruiting

Other trials in Belgium

About this study

Official title: Evaluation of Central Cerebral Effects of Pulsed Dosed Radiofrequency (PRF) on the Lumbar Dorsal Root Ganglion (DRG) Using Functional Magnetic Resonance Imaging (fMRI).

Evaluation of central (cerebral) effects of Pulsed RadioFrequency (PRF) on the lumbar DRG (Dorsal Root Ganglion), using fMRI (functional Magnetic Resonance Imaging ). Feasibility study (after which an interim analysis is done): 5 subjects in order to detect measurable central effects inducted by PRF on DRG, follow up study 20. Total amount of subjects 25.

Read the detailed description

Detect and prove the central effects of PRF and show the objective working mechanism.

PRF is often used technique to alleviate chronic radicular neuropathic pain, although good clinical results are observed the precise (central ) working mechanism is still unknown. This study aims to find the central working mechanism.

The investigator postulate the existence of central -cerebral effect of PRF on the DRG (dorsal root ganglion). If the investigator can detect the effect using fMRI and demonstrate the objective unequivocal proof that PRF on the DRG works than the investigator will be able to promote this technique for further use in the chronic pain states.

Being tested
Pulsed Radiofrequency
Keywords
fMRI, PRF
Medical subject headings
Radiculopathy, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulsed RadiofrequencyDevice

    Pulsed Radiofrequency is performed if the sensory threshold is below 0.5 volts, the PRF consists of 380 pulses

Study groups in NCT03185442
Study groupRoleWhat they receive
PRF-fMRIExperimentalNot described
Receives: Device: Pulsed Radiofrequency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Central working mechanism

    fMRI-BOLD

    Measured: 6 weeks

Secondary outcomes (2)
  1. Central working mechanism

    Numeric Rating Scale (NRS)

    Measured: 3 times in 6 weeks

  2. Central working mechanism

    Douleur Neuropathique Questionnaire 4 (DN 4)

    Measured: 2 times in 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2017
  2. Study start2 Jul 2018
  3. Primary completion15 Jul 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03185442
Sponsor's protocol ID
fMRI-PRF-DRG v 1.0
Status last verified
Apr 2019
First submitted
22 May 2017
Last updated
17 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pulsed Radiofrequency in people with Lumbar Radiculopathy and Chronic Disease, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Veerle Van Mossevelde, Data Nurse (+3224763134, veerle.vanmossevelde@uzbrussel.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Central working mechanism (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in